Patents by Inventor Tadamitsu Kishimoto

Tadamitsu Kishimoto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for treating thrombocytopenia
    Patent number: 5126325
    Abstract: Thrombocytopenia is treated by administering to a subject a therapeutic amount of human B cell differentiation factor or its biological equivalent.
    Type: Grant
    Filed: January 10, 1990
    Date of Patent: June 30, 1992
    Assignees: Ajinomoto Co., Inc., Tadamitsu Kishimoto
    Inventors: Tadamitsu Kishimoto, Toshio Hirano, Hideo Kimura, Toshiyuki Ishibashi, Yukio Akiyama, Akira Okano
  • Human cultured cell line
    Patent number: 4675291
    Abstract: This invention provides a novel cultured cell line which is derived from human T leukemic cells and which produces a colony-stimulating factor (CSF). This invention also provides a process for preparing such human cultured cell line, and a process of producing a CSF from such cell line.
    Type: Grant
    Filed: March 6, 1984
    Date of Patent: June 23, 1987
    Assignee: Otsuka Pharmaceutical Co., Ltd.
    Inventors: Yuichi Yamamura, Tadamitsu Kishimoto, Satoru Nakai, Yoshikatsu Hirai
  • Human T cell lines and method of producing same
    Patent number: 4544632
    Abstract: This invention provides a human parental T cell line which can fuse with normal human T cells, and hybrid cell lines which are prepared by fusion of the human parental T cells and the human T cells, and which are capable of producing lymphokines. This invention also provides methods of obtaining such human T cell lines, and a method of producing lymphokines from such hybrid cell lines.
    Type: Grant
    Filed: June 2, 1982
    Date of Patent: October 1, 1985
    Inventors: Yuichi Yamamura, Tadamitsu Kishimoto